SPECTRIAN CORP /CA/
S-8 POS, 1997-10-21
RADIO & TV BROADCASTING & COMMUNICATIONS EQUIPMENT
Previous: MILLER INDUSTRIES INC /TN/, 424B3, 1997-10-21
Next: COMMUNITY MEDICAL TRANSPORT INC, S-3, 1997-10-21



        As filed with the Securities and Exchange Commission on October 21, 1997
                   Registration Nos. 33-83832, 333-1046, 333-06385 and 333-25435
================================================================================


                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                               -------------------
                         POST EFFECTIVE AMENDMENT NO. 1
                                   TO FORM S-8
                             REGISTRATION STATEMENTS
                                      Under
                           The Securities Act of 1933
                               -------------------
                              SPECTRIAN CORPORATION
             (Exact name of Registrant as specified in its charter)
                               -------------------

       Delaware                                          77-0023003 
- ------------------------                    ------------------------------------
(State of incorporation)                    (I.R.S. Employer Identification No.)
  
                               350 West Java Drive
                           Sunnyvale, California 94089
   (Address, including zip code, of Registrant's principal executive offices)
                               -------------------
                                 1992 STOCK PLAN
                        1994 EMPLOYEE STOCK PURCHASE PLAN
                            1994 DIRECTOR OPTION PLAN
                      NON-QUALIFIED STOCK OPTION AGREEMENTS
                            (Full title of the plans)
                               -------------------
                                 BRUCE R. WRIGHT
                            Executive Vice President,
                           Finance and Administration,
                      Chief Financial Officer and Secretary
                              Spectrian Corporation
                               350 West Java Drive
                           Sunnyvale, California 94089
                                 (408) 745-5400
(Name, address, and telephone number, including area code, of agent for service)
                               -------------------
                                   Copies to:
                             CHRIS F. FENNELL, ESQ.
                        Wilson Sonsini Goodrich & Rosati
                            Professional Corporation
                               650 Page Mill Road
                            Palo Alto, CA 94304-1050
                                 (650) 493-9300

<TABLE>
<CAPTION>
                                                    CALCULATION OF REGISTRATION FEE
====================================================================================================================================
<S>                                         <C>                    <C>                    <C>                       <C>
                                                                   Proposed Maximum        Proposed Maximum          Amount of
   Title of Each Class of Securities        Amount to be            Offering Price        Aggregate Offering        Registration
            to be Registered                 Registered               Per Share                  Price                  Fee
- ------------------------------------------------------------------------------------------------------------------------------------
See Below.*                                      N/A*                   N/A*                     N/A*                 N/A*
====================================================================================================================================
<FN>
*  No additional securities are to be registered, and registration fees were paid upon filing of the original Registration Statement
   Nos. 33-83832, 333-1046, 333-06385 and 333-25435. Therefore, no further registration fee is required.
====================================================================================================================================
</FN>
</TABLE>
 
<PAGE>



                              SPECTRIAN CORPORATION
                        POST-EFFECTIVE AMENDMENT NO. 1 TO
                       REGISTRATION STATEMENTS ON FORM S-8

                                EXPLANATORY NOTE

         This Post-Effective  Amendment No. 1 (the "Amendment") to those certain
Registration Statements on Form S-8 (File Nos. 33-83832, 333-1046, 333-06385 and
333-25435) (the  "Registration  Statements") is being filed pursuant to Rule 414
under  the  Securities  Act  of  1933,  as  amended  (the  "Act")  by  Spectrian
Corporation,  a Delaware corporation ("Spectrian Delaware" or the "Registrant"),
which is the  successor  to  Spectrian  Corporation,  a  California  corporation
("Spectrian  California"),  following a statutory merger effective on October 3,
1997 (the "Merger") for the purpose of changing Spectrian  California's state of
incorporation.  Prior  to  the  Merger,  Spectrian  Delaware  had no  assets  or
liabilities  other than nominal assets or  liabilities.  In connection  with the
Merger,  Spectrian  Delaware  succeeded by operation of law to all of the assets
and  liabilities  of  Spectrian  California.  The  Merger  was  approved  by the
shareholders  of  Spectrian  California  at a  meeting  for which  proxies  were
solicited  pursuant to Section 14(a) of the Securities  Exchange Act of 1934, as
amended (the "1934 Act").

         Except as modified by this  Amendment  No. 1,  Spectrian  Delaware,  by
virtue of this Amendment,  expressly adopts the  Registration  Statements as its
own registration statements for all purposes of the Act and the 1934 Act.



                                      II-1

<PAGE>

                                     PART II

               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT


Item 3.   Incorporation of Documents by Reference.

          The contents of the Registration Statements are incorporated herein by
reference.  In  addition,  there are hereby  incorporated  by  reference in this
Amendment to the Registration Statements the following documents and information
heretofore filed with the Securities and Exchange Commission:

          (a) The  Registrant's  Annual  Report on Form 10-K for the fiscal year
ended March 31, 1997, filed pursuant to Section 13 of the 1934 Act;

          (b) The Company's  Quarterly Report on Form 10-Q for the quarter ended
June 28, 1997, filed pursuant to Section 13 of the 1934 Act;

          (c) The  description  of the  Registrant's  Preferred  Share  Purchase
Rights  contained in the Registrant's  Registration  Statement on Form 8-A filed
January 17, 1997 pursuant to Section 12(g) of the 1934 Act;

          (d) The description of the Registrant's  Common Stock contained in the
Registrant's  Registration  Statement on Form 8-A filed June 9, 1994 pursuant to
Section 12(g) of the 1934 Act; and

          (e) The  description  of the  Registrant's  Common Stock and Preferred
Stock contained in the Registrant's Current Report on Form 8-K filed October 10,
1997 pursuant to Section 13 of the 1934 Act.

          All  documents  filed by the  Registrant  pursuant to Sections  13(a),
13(c),  14 and 15(d) of the 1934 Act on or after the date of this  Amendment  to
the  Registration  Statements,  and  prior  to the  filing  of a  post-effective
amendment  which  indicates that all securities  offered have been sold or which
deregisters  all  securities  then  remaining  unsold,  shall  be  deemed  to be
incorporated  by reference  herein and to be part hereof from the date of filing
such documents.

Item 4.   Description of Securities.

          Not Applicable.

Item 5.   Interest of Named Experts and Counsel.

          Not Applicable.


                                      II-2

<PAGE>


Item 6.   Indemnification of Directors and Officers.

          The Registrant's  Certificate of Incorporation limits the liability of
directors to the maximum extent permitted by Delaware law. Delaware law provides
that  directors  of a  corporation  will not be  personally  liable for monetary
damages for breach of their fiduciary duties as directors,  except for liability
(i)  for  any  breach  of  their  duty  of  loyalty  to the  corporation  or its
stockholders,  (ii)  for acts or  omissions  not in good  faith or that  involve
intentional  misconduct  or a  knowing  violation  of law,  (iii)  for  unlawful
payments of dividends or unlawful  stock  repurchases or redemptions as provided
in  section  174 of the  Delaware  General  Corporation  Law,  or  (iv)  for any
transaction from which the director derived an improper personal benefit.

          The  Registrant's  Bylaws provide that the Registrant  shall indemnify
its  directors  and officers and may indemnify its employees and other agents to
the  fullest   extent   permitted  by  law.   The   Registrant   believes   that
indemnification under its Bylaws covers at least negligence and gross negligence
on the part of  indemnified  parties.  The  Registrant's  Bylaws also permit the
Registrant to secure insurance on behalf of any officer,  director,  employee or
other  agent  for  any  liability  arising  out of his or her  actions  in  such
capacity, regardless of whether the Registrant would have the power to indemnify
him or her against such liability under the General Corporation Law of Delaware.
The  Registrant  currently has secured such  insurance on behalf of its officers
and directors.

          The Registrant has entered into  agreements to indemnify its directors
and officers,  in addition to  indemnification  provided for in the Registrant's
Bylaws.  Subject to certain  conditions,  these agreements,  among other things,
indemnify  the   Registrant's   directors  and  officers  for  certain  expenses
(including attorney's fees), judgments, fines and settlement amounts incurred by
any such person in any action or  proceeding,  including any action by or in the
right of the Registrant,  arising out of such person's services as a director or
officer of the Registrant, any subsidiary of the Registrant or any other company
or  enterprise  to which the  person  provides  services  at the  request of the
Registrant.

Item 7.   Exemption from Registration Claimed.
 
          Not Applicable.

Item 8.   Exhibits.
              
          Exhibit
          Number                           Document
          -------                          --------

          4.1             Stock Option Agreement dated 11/26/96 between
                          Registrant and Garrett A. Garrettson

          4.2             Stock Option Agreement dated 11/26/96 between
                          Registrant and Garrett A. Garrettson



                                      II-3

<PAGE>



          4.3              Stock  Option   Agreement  dated  3/24/97  between
                           Registrant and Bruce Wright

          4.4              Stock  Option   Agreement  dated  3/20/97  between
                           Registrant and Michael Morrione

          23.1             Independent Auditors' Consent

          24.1             Power of Attorney

Item 9.   Undertakings.

          (a)  The undersigned Registrant hereby undertakes:

                  (1) To file,  during any  period in which  offers or sales are
being made, a post-effective amendment to these registration statements:

                      (i) To include any prospectus required by Section 10(a)(3)
of the Act;

                      (ii) To  reflect  in the  prospectus  any  facts or events
arising  after the  effective  date of the  registration  statement (or the most
recent  post-effective   amendment  thereof)  which,   individually  or  in  the
aggregate,  represent a fundamental  change in the  information set forth in the
registration statement;

                      (iii) To include any material  information with respect to
the plan of distribution not previously disclosed in the registration  statement
or any material change to such information in the registration statement.

          Provided,  however,  that  paragraphs  (a)(1)(i) and (a)(1)(ii) do not
apply  if the  registration  statement  is on Form  S-3,  or Form  S-8,  and the
information  required  to be  included in a  post-effective  amendment  by those
paragraphs is contained in periodic reports filed by the registrant  pursuant to
Section 13 or Section 15(d) of the 1934 Act that are  incorporated  by reference
in the registration statement.

                      (2) That,  for the purpose of  determining  any  liability
under the Act, each such  post-effective  amendment  shall be deemed to be a new
registration  statement  relating to the  securities  offered  therein,  and the
offering of such  securities at that time shall be deemed to be the initial bona
fide offering thereof.

                      (3)  To   remove   from   registration   by   means  of  a
post-effective  amendment any of the securities  being  registered  which remain
unsold at the termination of the offering.

          (b) The undersigned Registrant hereby undertakes that, for purposes of
determining any liability under the Act, each filing of the Registrant's  annual
report pursuant to

                                      II-4

<PAGE>


Section  13(a) or Section  15(d) of the 1934 Act (and,  where  applicable,  each
filing of an employee  benefit plan's annual report pursuant to Section 15(d) of
the 1934 Act) that is  incorporated by reference in the  registration  statement
shall be deemed to be a new  registration  statement  relating to the securities
offered  therein,  and the  offering  of such  securities  at that time shall be
deemed to be the initial bona fide offering thereof.

                  (c) Insofar as indemnification  for liabilities  arising under
the Act may be permitted to directors,  officers and controlling  persons of the
Registrant  pursuant to Delaware  General  Corporation  Law, the  Certificate of
Incorporation  and the  Bylaws  of the  Registrant,  Indemnification  Agreements
entered  into  between  the  Registrant  and  its  officers  and  directors,  or
otherwise, the Registrant has been advised that in the opinion of the Securities
and  Exchange  Commission  such  indemnification  is  against  public  policy as
expressed in the Act and is, therefore, unenforceable. In the event that a claim
for  indemnification  against  such  liabilities  (other than the payment by the
Registrant of expenses  incurred or paid by a director,  officer or  controlling
person of the  Registrant  in the  successful  defense  of any  action,  suit or
proceeding)  is  asserted by such  director,  officer or  controlling  person in
connection with the securities being registered hereunder,  the Registrant will,
unless in the opinion of its counsel the matter has been settled by  controlling
precedent,  submit to a court of appropriate  jurisdiction  the question whether
such  indemnification by it is against public policy as expressed in the Act and
will be governed by the final adjudication of such issue.


                                      II-5

<PAGE>

                                   SIGNATURES


          Pursuant  to the  requirements  of the  Securities  Act  of  1933,  as
amended, the Registrant certifies that it has reasonable grounds to believe that
it meets all of the requirements for filing on Form S-8 and has duly caused this
Post-Effective  Amendment No. 1 to Form S-8 Registration Statements to be signed
on its behalf by the  undersigned,  thereunto  duly  authorized,  in the City of
Sunnyvale, State of California, on this _____ day of October, 1997.


                              SPECTRIAN CORPORATION



                              By:
                                  ----------------------------------------------
                                   Bruce R. Wright
                                   Executive Vice President, Finance and
                                   Administration, Chief Financial Officer and
                                   Secretary (Principal Financial and Accounting
                                   Officer)


                                      II-6


<PAGE>
                                POWER OF ATTORNEY


             KNOW  ALL  PERSONS  BY  THESE  PRESENTS,  that  each  person  whose
signature appears below constitutes and appoints Garrett A. Garrettson and Bruce
R. Wright, jointly and severally, his attorneys-in-fact,  each with the power of
substitution,  for him in any and all capacities, to sign any amendments to this
Registration  Statement on Form S-8 and to file the same, with exhibits  thereto
and other  documents in connection  therewith,  with the Securities and Exchange
Commission,   hereby   ratifying   and   confirming   all  that   each  of  said
attorneys-in-fact,  or his substitute or substitutes, may do or cause to be done
by virtue hereof.

             Pursuant to the  requirements  of the Securities Act of 1933,  this
Post-Effective  Amendment No. 1 to the  Registration  Statements on Form S-8 has
been  signed  by the  following  persons  in  the  capacities  and on the  dates
indicated.


      Signature                         Title                         Date
- -----------------------     -------------------------------     ----------------

/s/ Garret A. Garrettson    President, Chief Executive          October 21, 1997
- ------------------------    Officer and Director                              
(Garrett A. Garrettson)     (Principal Executive Officer)                     
                                                                              
                            
/s/ Bruce R. Wright         Executive Vice President,           October 21, 1997
- -----------------------     Finance and Administration,                        
(Bruce R. Wright)           Chief Financial Officer and                        
                            Secretary (Principal Financial                     
                            and Accounting Officer)                            
                            
                          
/s/ James A. Cole           Director                            October 21, 1997
- -----------------------     
(James A. Cole)           
                          

/s/ Martin Cooper           Director                            October 21, 1997
- -----------------------     
(Martin Cooper)           

                          
/s/ Robert C. Wilson        Director                            October 21, 1997
- -----------------------    
(Robert C. Wilson)        

                          
/s/ Eric A. Young           Director                            October 21, 1997
- -----------------------     
(Eric A. Young)          


                                      II-7

<PAGE>




                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549




                                    EXHIBITS


                        Post Effective Amendment No. 1 to
                       Registration Statements on Form S-8

                              SPECTRIAN CORPORATION

                                October 21, 1997









<PAGE>



                              SPECTRIAN CORPORATION

                        POST EFFECTIVE AMENDMENT NO. 1 TO
                       REGISTRATION STATEMENTS ON FORM S-8


                                INDEX TO EXHIBITS





    Exhibit      
    Number                       Description                              Page 
- --------------   --------------------------------------------------    ---------
     4.1         Stock Option Agreement dated 11/26/96 between
                 Registrant and Garrett A. Garrettson

     4.2         Stock Option Agreement dated 11/26/96 between
                 Registrant and Garrett A. Garrettson

     4.3         Stock Option Agreement dated 3/24/97 between
                 Registrant and Bruce Wright

     4.4         Stock Option Agreement dated 3/20/97 between
                 Registrant and Michael Morrione

     23.1        Independent Auditors' Consent
 
     24.1        Power of Attorney (contained in page II-7)
 

 
 

<TABLE>
<CAPTION>

                                             SEE REVERSE SIDE FOR STOCK OPTION AGREEMENT



GARRETTSON, GARRETT A.
14495 Miranda Road
Los Altos Hills, CA 94022
                                                          [GRAPHIC OMITTED]

                                                        SPECTRIAN CORPORATION

                                                    NOTICE OF STOCK OPTION GRANT

You have been granted an option to purchase Common Stock of Spectrian  Corporation  (the "Company") under the terms of the Spectrian
Corporation 1992 Stock Plan as follows:

         <S>                                    <C>                        <C>                               <C>
         Grant Number                           003205                     Type of Option                    NQ          
         Date of Grant                          08/27/96                   Plan                              96GG
         Option Price Per Share                 $14.5000                   Term/Expiration Date              04/17/2006
         Total Number of Shares Granted         231,288                    Vesting Commencement Date         04/23/96

Vesting Schedule: This Option shall be exercisable  cumulatively,  to the extent of 1/48th of the total Number of Shares Granted for
each full calendar month of your  Continuous  Status as an Employee or Consultant  since the Vesting  Commencement  Date;  provided,
however,  that this Option shall not be exercisable  prior to one year from the Vesting  Commencement  Date.  Termination  Period: 3
months after termination of employment or consulting relationship (but in no event later than the Expiration Date).

                                                                                             SPECTRIAN CORPORATION

                                                                                    By:      /s/ Edward A. Supplee, Jr.
                                                                                       -------------------------------
                                                                                    Title:           Exec. V.P.
                                                                                          ----------------------------

This Notice of Grant does not  represent a stock  interest in the  Company,  which shall occur only upon the  exercise of this stock
option pursuant to its terms.

</TABLE>

<PAGE>


                              SPECTRIAN CORPORATION
                             STOCK OPTION AGREEMENT

      1. Grant of Option.  The Plan  Administrator of Spectrian  Corporation,  a
California  corporation (the "Company"),  hereby grants to the Optionee named in
the Notice of Grant (the  "Optionee"),  an option (the  "Option")  to purchase a
total number of shares of Common Stock (the "Shares") set forth in the Notice of
Grant,  at the  exercise  price per share set forth in the  Notice of Grant (the
"Exercise  Price")  subject  to the terms,  definitions  and  provisions  of the
Spectrian Corporation 1992 Stock Plan (the "Plan") adopted by the Company, which
is incorporated herein by reference.  Unless otherwise defined herein, the terms
defined in the Plan shall have the same defined meanings in this Option.

           If designated an Incentive  Stock Option,  this Option is intended to
qualify as an Incentive Option as defined in Section 422A of the Code.

      2. Exercise of Option. This Option shall be exercisable during its term in
accordance with the Vesting Schedule set out in the Notice of Grant and with the
provisions of Section 9 of the Plan as follows:

          (i)     Right to Exercise.

                  (a) This  Option  may not be  exercised  for a  fraction  of a
share.

                  (b) In the  event of  Optionee's  death,  disability  or other
termination  of  employment,  the  exercisability  of the Option is  governed by
Sections 7, 8 and 9 below,  subject to the  limitation  contained in  subsection
2(i)(c).
                  (c) In no event may this Option be exercised after the date of
expiration of the term of this Option as set forth in the Notice of Grant.

         (ii) Method of Exercise.  This Option shall be  exercisable  by written
notice (in the form  available  from the Company) which shall state the election
to exercise  the Option,  the number of Shares in respect of which the Option is
being  exercised,  and  such  other  representations  and  agreements  as to the
holder's investment intent with respect to such shares of Common Stock as may be
required by the Company  pursuant to the  provisions  of the Plan.  Such written
notice  shall be signed by the  Optionee  and shall be delivered in person or by
certified  mail to the  Secretary  of the Company.  The written  notice shall be
accompanied by payment of the exercise price.  This Option shall be deemed to be
exercised upon receipt by the Company of such written notice  accompanied by the
Exercise Price.

                  No Shares will be issued pursuant to the exercise of an Option
unless such issuance and such exercise shall comply with all relevant provisions
of law and the requirements of any stock exchange upon which the Shares may then
be listed. Assuming such compliance, for income tax purposes the Shares shall be
considered  transferred  to the  Optionee  on the date on which  the  Option  is
exercised with respect to such Shares.

      3.  Optionee's  Representations.  In  the  event  the  Shares  purchasable
pursuant  to the  exercise of this  Option  have not been  registered  under the
Securities  Act of 1933,  as  amended,  at the time this  Option  is  exercised,
Optionee  shall, if required by the Company,  concurrently  with the exercise of
all or any  portion  of this  Option,  deliver  to the  Company  his  Investment
Representation Statement in the form provided by the Company, and shall read the
applicable rules of the Commissioner of Corporations attached to such Investment
Representation Statement.


<PAGE>

      4. Method of Payment. Payment of the Exercise Price shall be by any of the
following, or a combination thereof, at the election of the Optionee:

          (i)     cash; or

         (ii)     check; or

        (iii) surrender of other shares of Common Stock of the Company which (A)
either have been owned by the  Optionee for more than six (6) months on the date
of surrender or were not acquired,  directly or indirectly, from the Company and
(B) have a fair  market  value on the date of  surrender  equal to the  Exercise
Price of the Shares as to which the Option is being exercised.

      5.  Restrictions on Exercise.  This Option may not be exercised until such
time as the Plan has been approved by the shareholders of the Company, or if the
issuance  of such  Shares  upon  such  exercise  or the  method  of  payment  of
consideration  for such shares would  constitute  a violation of any  applicable
federal or state securities or other law or regulation, including any rule under
Part  207 of Title 12 of the Code of  Federal  Regulations  ("Regulation  G") as
promulgated by the Federal Reserve Board. As a condition to the exercise of this
Option, the Company may require Optionee to make any representation and warranty
to the Company as may be required by any applicable law or regulation.

      6. Section 16 Restrictions.  Options granted to persons who are subject to
Section 16 of the Exchange Act ("Insiders") may not be exercised for a period of
at least  six  months  from the date of  grant,  except  in the case of death or
disability.

      7. Termination of Relationship.  In the event Optionee's Continuous Status
as an Employee or consultant  terminates,  Optionee may, to the extent otherwise
so entitled at the date of such termination (the "Termination  Date"),  exercise
this Option during the Termination Period set out in the Notice of Grant. To the
extent that  Optionee  was not  entitled to exercise  this Option at the date of
such  termination,  or if the Optionee  does not exercise this Option within the
time specified herein, the Option shall terminate.

      8.  Disability of Optionee.  Notwithstanding  the  provisions of Section 7
above, in the event  Optionee's  Continuous  Status as an Employee or Consultant
terminates as a result of total and permanent  disability (as defined in Section
22(e)(3) of the Code), Optionee may, but only within twelve (12) months from the
date of termination of employment or consultancy (but in no event later than the
date of expiration of the term of this Option as set forth in Section 11 below),
exercise  the Option to the extent  otherwise  so  entitled  at the date of such
termination. To the extent that Optionee was not entitled to exercise the Option
at the date of termination, or if Optionee does not exercise such Option (to the
extent otherwise so entitled) within the time specified herein, the Option shall
terminate.

      9.  Death of  Optionee.  The Option may be  exercised  at any time  within
twelve (12) months  after the  Optionee's  death (but in no event later than the
date of expiration of the term of this Option as set forth in Section 11 below),
by  Optionee's  estate or by a person who  acquired  the right to  exercise  the
Option by bequest or  inheritance,  but only to the  extent the  Optionee  could
exercise the Option at the date of death.

      10.  Non-Transferability  of Option. This Option may not be transferred or
assigned  in any  manner  otherwise  than by will or by the laws of  descent  or
distribution  and may be exercised  during the lifetime of Optionee only by him.
The terms of this Option  shall be binding upon the  executors,  administrators,
heirs, successors and assigns of the Optionee.


<PAGE>

      11. Term of Option.  This Option may be exercised only within the term set
out in the  Notice  of  Grant,  and may be  exercised  during  such term only in
accordance with the Plan and the terms of this Option.

      12. Tax Consequences. Set forth below is a brief summary as of the date of
this Option of some of the federal tax  consequences  of exercise of this Option
and disposition of the Shares. THIS SUMMARY IS NECESSARILY  INCOMPLETE,  AND THE
TAX LAWS AND  REGULATIONS  ARE SUBJECT TO CHANGE.  OPTIONEE SHOULD CONSULT A TAX
ADVISER BEFORE EXERCISING THIS OPTION OR DISPOSING OF THE SHARES.

          (i) Exercise of ISO. If this Option qualifies as an ISO, there will be
no regular  federal  income  tax  liability  upon the  exercise  of the  Option,
although the excess,  if any, of the fair market value of the Shares on the date
of exercise  over the  Exercise  Price will be treated as an  adjustment  to the
alternative minimum tax for federal tax purposes and may subject the Optionee to
the alternative minimum tax.

         (ii) Exercise of  Nonqualified  Stock  Option.  If this Option does not
qualify as an ISO, there may be a regular  federal income tax liability upon the
exercise  of the  Option.  The  Optionee  will be  treated  as  having  received
compensation  income (taxable at ordinary income tax rates) equal to the excess,
if any, of the fair market value of the Shares on the date of exercise  over the
Exercise  Price.  If Optionee is an  employee,  the Company  will be required to
withhold from  Optionee's  compensation  or collect from Optionee and pay to the
applicable  taxing   authorities  an  amount  equal  to  a  percentage  of  this
compensation income at the time of exercise.

        (iii)  Disposition of Shares.  In the case of an NSO, if Shares are held
for at least one year,  any gain realized on  disposition  of the Shares will be
treated as long-term  capital gain for federal income tax purposes.  In the case
of an ISO,  if Shares  transferred  pursuant to the Option are held for at least
one year after exercise and are disposed of at least two years after the Date of
Grant,  any gain realized on  disposition  of the Shares will also be treated as
long-term  capital gain for federal  income tax  purposes.  If Shares  purchased
under an ISO are  disposed  of within such  one-year  period or within two years
after the Date of Grant,  any gain realized on such  disposition will be treated
as  compensation  income (taxable at ordinary income rates) to the extent of the
excess,  if any, of the fair market  value of the Shares on the date of exercise
over the Exercise Price.

         (iv) Notice of Disqualifying  Disposition of ISO Shares.  If the Option
granted  to  Optionee  herein  is an ISO,  and if  Optionee  sells or  otherwise
disposes  of any of the  Shares  acquired  pursuant  to the ISO on or before the
later of (1) the date two years  after  the Date of  Grant,  or (2) the date one
year after transfer of such Shares to the Optionee upon exercise of the ISO, the
Optionee shall  immediately  notify the Company in writing of such  disposition.
Optionee  agrees that Optionee may be subject to income tax  withholding  by the
Company on the  compensation  income  recognized  by the Optionee from the early
disposition  by  payment  in cash  or out of the  current  earnings  paid to the
Optionee.

      OPTIONEE  ACKNOWLEDGES  AND AGREES THAT THE VESTING OF SHARES  PURSUANT TO
THE OPTION HEREOF IS EARNED ONLY BY CONTINUING  CONSULTANCY OR EMPLOYMENT AT THE
WILL OF THE COMPANY  (NOT  THROUGH THE ACT OF BEING  HIRED,  BEING  GRANTED THIS
OPTION OR ACQUIRING SHARES HEREUNDER).  OPTIONEE FURTHER ACKNOWLEDGES AND AGREES
THAT  NOTHING  IN THIS  OPTION,  NOR IN THE  COMPANY'S  1992 STOCK PLAN WHICH IS
INCORPORATED HEREIN BY REFERENCE, SHALL CONFER UPON OPTIONEE ANY


<PAGE>

RIGHT WITH RESPECT TO  CONTINUATION OF EMPLOYMENT OR CONSULTANCY BY THE COMPANY,
NOR  SHALL IT  INTERFERE  IN ANY WAY WITH HIS  RIGHT OR THE  COMPANY'S  RIGHT TO
TERMINATE HIS EMPLOYMENT OR CONSULTANCY AT ANY TIME, WITH OR WITHOUT CAUSE.

      Optionee   acknowledges  receipt  of  a  copy  of  the  Plan  and  certain
information,  related  thereto and represents that he is familiar with the terms
and  provisions  thereof,  and hereby  accepts this Option subject to all of the
terms and provisions of the Plan. Optionee has reviewed the Plan and this Option
in their entirety,  has had an opportunity to obtain the advice of counsel prior
to executing this Option and fully  understands all provisions  relating to this
Option.  Optionee  hereby agrees to accept as binding,  conclusive and final all
decisions or  interpretations  of the Board upon any questions arising under the
Plan or this Option.

                                                 /s/ Garrett A. Garrettson
Dated: November 26, 1996                         _______________________________
                                                 Optionee Signature


Dissolution, Merger or Assets Sale.

         Notwithstanding  the  foregoing  Vesting  Schedule,  in the  event of a
Change of Control of the Company,  the Optionee shall have the right to exercise
this Option as to all of the Shares,  including  Shares as to which it would not
otherwise be  exercisable.  "Change of Control" shall mean the occurrence of any
of the following events:

                   (i)  Any  "person"  or  "group"  (as  such  term  is  used in
Sections 13(d) and 14(d) of the Securities  Exchange Act of 1934, as amended) is
or becomes the  "beneficial  owner" (as defined in  Rule 13d-3  under said Act),
directly or indirectly, of securities of the Company representing 50% or more of
the total voting power  represented  by the Company's  then  outstanding  voting
securities; or

                   (ii) A change in the  composition of the Board of the Company
occurring within a two-year  period,  as a result of which fewer than a majority
of the directors  are  Incumbent  Directors.  "Incumbent  Directors"  shall mean
directors who either (A) are  directors of the Company as of the date hereof, or
(B) are elected, or nominated for election, to the Board of the Company with the
affirmative votes of at least a majority of the Incumbent  Directors at the time
of such  election  or  nomination  (but shall not  include an  individual  whose
election or  nomination  is in  connection  with an actual or  threatened  proxy
contest relating to the election of directors to the Company); or

                   (iii) The  shareholders  of the  Company  approve a merger or
consolidation of the Company with any other corporation,  other than a merger or
consolidation  which  would  result  in the  voting  securities  of the  Company
outstanding  immediately  prior  thereto  continuing  to  represent  (either  by
remaining  outstanding  or by being  converted  into  voting  securities  of the
surviving  entity)  more than  fifty  percent  (50%) of the total  voting  power
represented  by the voting  securities of the Company or such  surviving  entity
outstanding immediately after such merger or consolidation,  or the shareholders
of the  Company  approve a plan of  complete  liquidation  of the  Company or an
agreement for the sale or disposition by the Company of all or substantially all
the Company's assets (other than to a subsidiary or subsidiaries).


<TABLE>
<CAPTION>

                                             SEE REVERSE SIDE FOR STOCK OPTION AGREEMENT



GARRETTSON, GARRETT A.
14495 Miranda Road
Los Altos Hills, CA 94022
                                                          [GRAPHIC OMITTED]

                                                        SPECTRIAN CORPORATION

                                                    NOTICE OF STOCK OPTION GRANT

You have been granted an option to purchase Common Stock of Spectrian  Corporation  (the "Company") under the terms of the Spectrian
Corporation 1992 Stock Plan as follows:

         <S>                                    <C>                        <C>                               <C>
         Grant Number                           003206                     Type of Option                   NQ
         Date of Grant                          08/27/96                   Plan                             96GG
         Option Price Per Share                 $14.5000                   Term/Expiration Date             04/17/2006
         Total Number of Shares Granted         18,712                     Vesting Commencement Date        04/23/96

Vesting Schedule: This Option shall be exercisable  cumulatively,  to the extent of 1/48th of the total Number of Shares Granted for
each full calendar month of your  Continuous  Status as an Employee or Consultant  since the Vesting  Commencement  Date;  provided,
however,  that this Option shall not be exercisable  prior to one year from the Vesting  Commencement  Date.  Termination  Period: 3
months after termination of employment or consulting relationship (but in no event later than the Expiration Date).

                                                                                             SPECTRIAN CORPORATION

                                                                                    By:      /s/ Edward A. Supplee, Jr.
                                                                                       -------------------------------
                                                                                    Title:           Exec. V.P.
                                                                                          ----------------------------

This Notice of Grant does not  represent a stock  interest in the  Company,  which shall occur only upon the  exercise of this stock
option pursuant to its terms.

</TABLE>

<PAGE>


                              SPECTRIAN CORPORATION
                             STOCK OPTION AGREEMENT

      1. Grant of Option.  The Plan  Administrator of Spectrian  Corporation,  a
California  corporation (the "Company"),  hereby grants to the Optionee named in
the Notice of Grant (the  "Optionee"),  an option (the  "Option")  to purchase a
total number of shares of Common Stock (the "Shares") set forth in the Notice of
Grant,  at the  exercise  price per share set forth in the  Notice of Grant (the
"Exercise  Price")  subject  to the terms,  definitions  and  provisions  of the
Spectrian Corporation 1992 Stock Plan (the "Plan") adopted by the Company, which
is incorporated herein by reference.  Unless otherwise defined herein, the terms
defined in the Plan shall have the same defined meanings in this Option.

           If designated an Incentive  Stock Option,  this Option is intended to
qualify as an Incentive Option as defined in Section 422A of the Code.

      2. Exercise of Option. This Option shall be exercisable during its term in
accordance with the Vesting Schedule set out in the Notice of Grant and with the
provisions of Section 9 of the Plan as follows:

          (i)     Right to Exercise.

                  (a) This  Option  may not be  exercised  for a  fraction  of a
share.

                  (b) In the  event of  Optionee's  death,  disability  or other
termination  of  employment,  the  exercisability  of the Option is  governed by
Sections 7, 8 and 9 below,  subject to the  limitation  contained in  subsection
2(i)(c).
                  (c) In no event may this Option be exercised after the date of
expiration of the term of this Option as set forth in the Notice of Grant.

         (ii) Method of Exercise.  This Option shall be  exercisable  by written
notice (in the form  available  from the Company) which shall state the election
to exercise  the Option,  the number of Shares in respect of which the Option is
being  exercised,  and  such  other  representations  and  agreements  as to the
holder's investment intent with respect to such shares of Common Stock as may be
required by the Company  pursuant to the  provisions  of the Plan.  Such written
notice  shall be signed by the  Optionee  and shall be delivered in person or by
certified  mail to the  Secretary  of the Company.  The written  notice shall be
accompanied by payment of the exercise price.  This Option shall be deemed to be
exercised upon receipt by the Company of such written notice  accompanied by the
Exercise Price.

                  No Shares will be issued pursuant to the exercise of an Option
unless such issuance and such exercise shall comply with all relevant provisions
of law and the requirements of any stock exchange upon which the Shares may then
be listed. Assuming such compliance, for income tax purposes the Shares shall be
considered  transferred  to the  Optionee  on the date on which  the  Option  is
exercised with respect to such Shares.

      3.  Optionee's  Representations.  In  the  event  the  Shares  purchasable
pursuant  to the  exercise of this  Option  have not been  registered  under the
Securities  Act of 1933,  as  amended,  at the time this  Option  is  exercised,
Optionee  shall, if required by the Company,  concurrently  with the exercise of
all or any  portion  of this  Option,  deliver  to the  Company  his  Investment
Representation Statement in the form provided by the Company, and shall read the
applicable rules of the Commissioner of Corporations attached to such Investment
Representation Statement.


<PAGE>

      4. Method of Payment. Payment of the Exercise Price shall be by any of the
following, or a combination thereof, at the election of the Optionee:

          (i)     cash; or

         (ii)     check; or

        (iii) surrender of other shares of Common Stock of the Company which (A)
either have been owned by the  Optionee for more than six (6) months on the date
of surrender or were not acquired,  directly or indirectly, from the Company and
(B) have a fair  market  value on the date of  surrender  equal to the  Exercise
Price of the Shares as to which the Option is being exercised.

      5.  Restrictions on Exercise.  This Option may not be exercised until such
time as the Plan has been approved by the shareholders of the Company, or if the
issuance  of such  Shares  upon  such  exercise  or the  method  of  payment  of
consideration  for such shares would  constitute  a violation of any  applicable
federal or state securities or other law or regulation, including any rule under
Part  207 of Title 12 of the Code of  Federal  Regulations  ("Regulation  G") as
promulgated by the Federal Reserve Board. As a condition to the exercise of this
Option, the Company may require Optionee to make any representation and warranty
to the Company as may be required by any applicable law or regulation.

      6. Section 16 Restrictions.  Options granted to persons who are subject to
Section 16 of the Exchange Act ("Insiders") may not be exercised for a period of
at least  six  months  from the date of  grant,  except  in the case of death or
disability.

      7. Termination of Relationship.  In the event Optionee's Continuous Status
as an Employee or consultant  terminates,  Optionee may, to the extent otherwise
so entitled at the date of such termination (the "Termination  Date"),  exercise
this Option during the Termination Period set out in the Notice of Grant. To the
extent that  Optionee  was not  entitled to exercise  this Option at the date of
such  termination,  or if the Optionee  does not exercise this Option within the
time specified herein, the Option shall terminate.

      8.  Disability of Optionee.  Notwithstanding  the  provisions of Section 7
above, in the event  Optionee's  Continuous  Status as an Employee or Consultant
terminates as a result of total and permanent  disability (as defined in Section
22(e)(3) of the Code), Optionee may, but only within twelve (12) months from the
date of termination of employment or consultancy (but in no event later than the
date of expiration of the term of this Option as set forth in Section 11 below),
exercise  the Option to the extent  otherwise  so  entitled  at the date of such
termination. To the extent that Optionee was not entitled to exercise the Option
at the date of termination, or if Optionee does not exercise such Option (to the
extent otherwise so entitled) within the time specified herein, the Option shall
terminate.

      9.  Death of  Optionee.  The Option may be  exercised  at any time  within
twelve (12) months  after the  Optionee's  death (but in no event later than the
date of expiration of the term of this Option as set forth in Section 11 below),
by  Optionee's  estate or by a person who  acquired  the right to  exercise  the
Option by bequest or  inheritance,  but only to the  extent the  Optionee  could
exercise the Option at the date of death.

      10.  Non-Transferability  of Option. This Option may not be transferred or
assigned  in any  manner  otherwise  than by will or by the laws of  descent  or
distribution  and may be exercised  during the lifetime of Optionee only by him.
The terms of this Option  shall be binding upon the  executors,  administrators,
heirs, successors and assigns of the Optionee.


<PAGE>

      11. Term of Option.  This Option may be exercised only within the term set
out in the  Notice  of  Grant,  and may be  exercised  during  such term only in
accordance with the Plan and the terms of this Option.

      12. Tax Consequences. Set forth below is a brief summary as of the date of
this Option of some of the federal tax  consequences  of exercise of this Option
and disposition of the Shares. THIS SUMMARY IS NECESSARILY  INCOMPLETE,  AND THE
TAX LAWS AND  REGULATIONS  ARE SUBJECT TO CHANGE.  OPTIONEE SHOULD CONSULT A TAX
ADVISER BEFORE EXERCISING THIS OPTION OR DISPOSING OF THE SHARES.

          (i) Exercise of ISO. If this Option qualifies as an ISO, there will be
no regular  federal  income  tax  liability  upon the  exercise  of the  Option,
although the excess,  if any, of the fair market value of the Shares on the date
of exercise  over the  Exercise  Price will be treated as an  adjustment  to the
alternative minimum tax for federal tax purposes and may subject the Optionee to
the alternative minimum tax.

         (ii) Exercise of  Nonqualified  Stock  Option.  If this Option does not
qualify as an ISO, there may be a regular  federal income tax liability upon the
exercise  of the  Option.  The  Optionee  will be  treated  as  having  received
compensation  income (taxable at ordinary income tax rates) equal to the excess,
if any, of the fair market value of the Shares on the date of exercise  over the
Exercise  Price.  If Optionee is an  employee,  the Company  will be required to
withhold from  Optionee's  compensation  or collect from Optionee and pay to the
applicable  taxing   authorities  an  amount  equal  to  a  percentage  of  this
compensation income at the time of exercise.

        (iii)  Disposition of Shares.  In the case of an NSO, if Shares are held
for at least one year,  any gain realized on  disposition  of the Shares will be
treated as long-term  capital gain for federal income tax purposes.  In the case
of an ISO,  if Shares  transferred  pursuant to the Option are held for at least
one year after exercise and are disposed of at least two years after the Date of
Grant,  any gain realized on  disposition  of the Shares will also be treated as
long-term  capital gain for federal  income tax  purposes.  If Shares  purchased
under an ISO are  disposed  of within such  one-year  period or within two years
after the Date of Grant,  any gain realized on such  disposition will be treated
as  compensation  income (taxable at ordinary income rates) to the extent of the
excess,  if any, of the fair market  value of the Shares on the date of exercise
over the Exercise Price.

         (iv) Notice of Disqualifying  Disposition of ISO Shares.  If the Option
granted  to  Optionee  herein  is an ISO,  and if  Optionee  sells or  otherwise
disposes  of any of the  Shares  acquired  pursuant  to the ISO on or before the
later of (1) the date two years  after  the Date of  Grant,  or (2) the date one
year after transfer of such Shares to the Optionee upon exercise of the ISO, the
Optionee shall  immediately  notify the Company in writing of such  disposition.
Optionee  agrees that Optionee may be subject to income tax  withholding  by the
Company on the  compensation  income  recognized  by the Optionee from the early
disposition  by  payment  in cash  or out of the  current  earnings  paid to the
Optionee.

      OPTIONEE  ACKNOWLEDGES  AND AGREES THAT THE VESTING OF SHARES  PURSUANT TO
THE OPTION HEREOF IS EARNED ONLY BY CONTINUING  CONSULTANCY OR EMPLOYMENT AT THE
WILL OF THE COMPANY  (NOT  THROUGH THE ACT OF BEING  HIRED,  BEING  GRANTED THIS
OPTION OR ACQUIRING SHARES HEREUNDER).  OPTIONEE FURTHER ACKNOWLEDGES AND AGREES
THAT  NOTHING  IN THIS  OPTION,  NOR IN THE  COMPANY'S  1992 STOCK PLAN WHICH IS
INCORPORATED HEREIN BY REFERENCE, SHALL CONFER UPON OPTIONEE ANY


<PAGE>

RIGHT WITH RESPECT TO  CONTINUATION OF EMPLOYMENT OR CONSULTANCY BY THE COMPANY,
NOR  SHALL IT  INTERFERE  IN ANY WAY WITH HIS  RIGHT OR THE  COMPANY'S  RIGHT TO
TERMINATE HIS EMPLOYMENT OR CONSULTANCY AT ANY TIME, WITH OR WITHOUT CAUSE.

      Optionee   acknowledges  receipt  of  a  copy  of  the  Plan  and  certain
information,  related  thereto and represents that he is familiar with the terms
and  provisions  thereof,  and hereby  accepts this Option subject to all of the
terms and provisions of the Plan. Optionee has reviewed the Plan and this Option
in their entirety,  has had an opportunity to obtain the advice of counsel prior
to executing this Option and fully  understands all provisions  relating to this
Option.  Optionee  hereby agrees to accept as binding,  conclusive and final all
decisions or  interpretations  of the Board upon any questions arising under the
Plan or this Option.

                                                 /s/ Garrett A. Garrettson
Dated: November 26, 1996                         _______________________________
                                                 Optionee Signature


Dissolution, Merger or Assets Sale.

         Notwithstanding  the  foregoing  Vesting  Schedule,  in the  event of a
Change of Control of the Company,  the Optionee shall have the right to exercise
this Option as to all of the Shares,  including  Shares as to which it would not
otherwise be  exercisable.  "Change of Control" shall mean the occurrence of any
of the following events:

                   (i)  Any  "person"  or  "group"  (as  such  term  is  used in
Sections 13(d) and 14(d) of the Securities  Exchange Act of 1934, as amended) is
or becomes the  "beneficial  owner" (as defined in  Rule 13d-3  under said Act),
directly or indirectly, of securities of the Company representing 50% or more of
the total voting power  represented  by the Company's  then  outstanding  voting
securities; or

                   (ii) A change in the  composition of the Board of the Company
occurring within a two-year  period,  as a result of which fewer than a majority
of the directors  are  Incumbent  Directors.  "Incumbent  Directors"  shall mean
directors who either (A) are  directors of the Company as of the date hereof, or
(B) are elected, or nominated for election, to the Board of the Company with the
affirmative votes of at least a majority of the Incumbent  Directors at the time
of such  election  or  nomination  (but shall not  include an  individual  whose
election or  nomination  is in  connection  with an actual or  threatened  proxy
contest relating to the election of directors to the Company); or

                   (iii) The  shareholders  of the  Company  approve a merger or
consolidation of the Company with any other corporation,  other than a merger or
consolidation  which  would  result  in the  voting  securities  of the  Company
outstanding  immediately  prior  thereto  continuing  to  represent  (either  by
remaining  outstanding  or by being  converted  into  voting  securities  of the
surviving  entity)  more than  fifty  percent  (50%) of the total  voting  power
represented  by the voting  securities of the Company or such  surviving  entity
outstanding immediately after such merger or consolidation,  or the shareholders
of the  Company  approve a plan of  complete  liquidation  of the  Company or an
agreement for the sale or disposition by the Company of all or substantially all
the Company's assets (other than to a subsidiary or subsidiaries).


<TABLE>
<CAPTION>

                                             SEE REVERSE SIDE FOR STOCK OPTION AGREEMENT



WRIGHT, BRUCE
350 W. Java Drive
Sunnyvale, CA 94089
                                                          [GRAPHIC OMITTED]

                                                        SPECTRIAN CORPORATION

                                                    NOTICE OF STOCK OPTION GRANT

You have been granted an option to purchase Common Stock of Spectrian  Corporation  (the "Company") under the terms of the Spectrian
Corporation 1992 Stock Plan as follows:

         <S>                                    <C>                        <C>                               <C>
         Grant Number                           003296                     Type of Option                    NQ
         Date of Grant                          3/13/97                    Plan                              96GG
         Option Price Per Share                 $13.7500                   Term/Expiration Date              3/13/2007
         Total Number of Shares Granted         100,000                    Vesting Commencement Date         3/18/97

Vesting Schedule: This Option shall be exercisable  cumulatively,  to the extent of 1/48th of the total Number of Shares Granted for
each full calendar month of your  Continuous  Status as an Employee or Consultant  since the Vesting  Commencement  Date;  provided,
however,  that this Option shall not be exercisable  prior to one year from the Vesting  Commencement  Date.  Termination  Period: 3
months after termination of employment or consulting relationship (but in no event later than the Expiration Date).

                                                                                             SPECTRIAN CORPORATION

                                                                                    By:      /s/ Garrett Garettson
                                                                                       -------------------------------
                                                                                    Title:            CEO
                                                                                          ----------------------------

This Notice of Grant does not  represent a stock  interest in the  Company,  which shall occur only upon the  exercise of this stock
option pursuant to its terms.

</TABLE>

<PAGE>


                              SPECTRIAN CORPORATION
                             STOCK OPTION AGREEMENT

      1. Grant of Option.  The Plan  Administrator of Spectrian  Corporation,  a
California  corporation (the "Company"),  hereby grants to the Optionee named in
the Notice of Grant (the  "Optionee"),  an option (the  "Option")  to purchase a
total number of shares of Common Stock (the "Shares") set forth in the Notice of
Grant,  at the  exercise  price per share set forth in the  Notice of Grant (the
"Exercise  Price")  subject  to the terms,  definitions  and  provisions  of the
Spectrian Corporation 1992 Stock Plan (the "Plan") adopted by the Company, which
is incorporated herein by reference.  Unless otherwise defined herein, the terms
defined in the Plan shall have the same defined meanings in this Option.

           If designated an Incentive  Stock Option,  this Option is intended to
qualify as an Incentive Option as defined in Section 422A of the Code.

      2. Exercise of Option. This Option shall be exercisable during its term in
accordance with the Vesting Schedule set out in the Notice of Grant and with the
provisions of Section 9 of the Plan as follows:

          (i)     Right to Exercise.

                  (a) This  Option  may not be  exercised  for a  fraction  of a
share.

                  (b) In the  event of  Optionee's  death,  disability  or other
termination  of  employment,  the  exercisability  of the Option is  governed by
Sections 7, 8 and 9 below,  subject to the  limitation  contained in  subsection
2(i)(c).
                  (c) In no event may this Option be exercised after the date of
expiration of the term of this Option as set forth in the Notice of Grant.

         (ii) Method of Exercise.  This Option shall be  exercisable  by written
notice (in the form  available  from the Company) which shall state the election
to exercise  the Option,  the number of Shares in respect of which the Option is
being  exercised,  and  such  other  representations  and  agreements  as to the
holder's investment intent with respect to such shares of Common Stock as may be
required by the Company  pursuant to the  provisions  of the Plan.  Such written
notice  shall be signed by the  Optionee  and shall be delivered in person or by
certified  mail to the  Secretary  of the Company.  The written  notice shall be
accompanied by payment of the exercise price.  This Option shall be deemed to be
exercised upon receipt by the Company of such written notice  accompanied by the
Exercise Price.

                  No Shares will be issued pursuant to the exercise of an Option
unless such issuance and such exercise shall comply with all relevant provisions
of law and the requirements of any stock exchange upon which the Shares may then
be listed. Assuming such compliance, for income tax purposes the Shares shall be
considered  transferred  to the  Optionee  on the date on which  the  Option  is
exercised with respect to such Shares.

      3.  Optionee's  Representations.  In  the  event  the  Shares  purchasable
pursuant  to the  exercise of this  Option  have not been  registered  under the
Securities  Act of 1933,  as  amended,  at the time this  Option  is  exercised,
Optionee  shall, if required by the Company,  concurrently  with the exercise of
all or any  portion  of this  Option,  deliver  to the  Company  his  Investment
Representation Statement in the form provided by the Company, and shall read the
applicable rules of the Commissioner of Corporations attached to such Investment
Representation Statement.


<PAGE>

      4. Method of Payment. Payment of the Exercise Price shall be by any of the
following, or a combination thereof, at the election of the Optionee:

          (i)     cash; or

         (ii)     check; or

        (iii) surrender of other shares of Common Stock of the Company which (A)
either have been owned by the  Optionee for more than six (6) months on the date
of surrender or were not acquired,  directly or indirectly, from the Company and
(B) have a fair  market  value on the date of  surrender  equal to the  Exercise
Price of the Shares as to which the Option is being exercised.

      5.  Restrictions on Exercise.  This Option may not be exercised until such
time as the Plan has been approved by the shareholders of the Company, or if the
issuance  of such  Shares  upon  such  exercise  or the  method  of  payment  of
consideration  for such shares would  constitute  a violation of any  applicable
federal or state securities or other law or regulation, including any rule under
Part  207 of Title 12 of the Code of  Federal  Regulations  ("Regulation  G") as
promulgated by the Federal Reserve Board. As a condition to the exercise of this
Option, the Company may require Optionee to make any representation and warranty
to the Company as may be required by any applicable law or regulation.

      6. Section 16 Restrictions.  Options granted to persons who are subject to
Section 16 of the Exchange Act ("Insiders") may not be exercised for a period of
at least  six  months  from the date of  grant,  except  in the case of death or
disability.

      7. Termination of Relationship.  In the event Optionee's Continuous Status
as an Employee or consultant  terminates,  Optionee may, to the extent otherwise
so entitled at the date of such termination (the "Termination  Date"),  exercise
this Option during the Termination Period set out in the Notice of Grant. To the
extent that  Optionee  was not  entitled to exercise  this Option at the date of
such  termination,  or if the Optionee  does not exercise this Option within the
time specified herein, the Option shall terminate.

      8.  Disability of Optionee.  Notwithstanding  the  provisions of Section 7
above, in the event  Optionee's  Continuous  Status as an Employee or Consultant
terminates as a result of total and permanent  disability (as defined in Section
22(e)(3) of the Code), Optionee may, but only within twelve (12) months from the
date of termination of employment or consultancy (but in no event later than the
date of expiration of the term of this Option as set forth in Section 11 below),
exercise  the Option to the extent  otherwise  so  entitled  at the date of such
termination. To the extent that Optionee was not entitled to exercise the Option
at the date of termination, or if Optionee does not exercise such Option (to the
extent otherwise so entitled) within the time specified herein, the Option shall
terminate.

      9.  Death of  Optionee.  The Option may be  exercised  at any time  within
twelve (12) months  after the  Optionee's  death (but in no event later than the
date of expiration of the term of this Option as set forth in Section 11 below),
by  Optionee's  estate or by a person who  acquired  the right to  exercise  the
Option by bequest or  inheritance,  but only to the  extent the  Optionee  could
exercise the Option at the date of death.

      10.  Non-Transferability  of Option. This Option may not be transferred or
assigned  in any  manner  otherwise  than by will or by the laws of  descent  or
distribution  and may be exercised  during the lifetime of Optionee only by him.
The terms of this Option  shall be binding upon the  executors,  administrators,
heirs, successors and assigns of the Optionee.


<PAGE>

      11. Term of Option.  This Option may be exercised only within the term set
out in the  Notice  of  Grant,  and may be  exercised  during  such term only in
accordance with the Plan and the terms of this Option.

      12. Tax Consequences. Set forth below is a brief summary as of the date of
this Option of some of the federal tax  consequences  of exercise of this Option
and disposition of the Shares. THIS SUMMARY IS NECESSARILY  INCOMPLETE,  AND THE
TAX LAWS AND  REGULATIONS  ARE SUBJECT TO CHANGE.  OPTIONEE SHOULD CONSULT A TAX
ADVISER BEFORE EXERCISING THIS OPTION OR DISPOSING OF THE SHARES.

          (i) Exercise of ISO. If this Option qualifies as an ISO, there will be
no regular  federal  income  tax  liability  upon the  exercise  of the  Option,
although the excess,  if any, of the fair market value of the Shares on the date
of exercise  over the  Exercise  Price will be treated as an  adjustment  to the
alternative minimum tax for federal tax purposes and may subject the Optionee to
the alternative minimum tax.

         (ii) Exercise of  Nonqualified  Stock  Option.  If this Option does not
qualify as an ISO, there may be a regular  federal income tax liability upon the
exercise  of the  Option.  The  Optionee  will be  treated  as  having  received
compensation  income (taxable at ordinary income tax rates) equal to the excess,
if any, of the fair market value of the Shares on the date of exercise  over the
Exercise  Price.  If Optionee is an  employee,  the Company  will be required to
withhold from  Optionee's  compensation  or collect from Optionee and pay to the
applicable  taxing   authorities  an  amount  equal  to  a  percentage  of  this
compensation income at the time of exercise.

        (iii)  Disposition of Shares.  In the case of an NSO, if Shares are held
for at least one year,  any gain realized on  disposition  of the Shares will be
treated as long-term  capital gain for federal income tax purposes.  In the case
of an ISO,  if Shares  transferred  pursuant to the Option are held for at least
one year after exercise and are disposed of at least two years after the Date of
Grant,  any gain realized on  disposition  of the Shares will also be treated as
long-term  capital gain for federal  income tax  purposes.  If Shares  purchased
under an ISO are  disposed  of within such  one-year  period or within two years
after the Date of Grant,  any gain realized on such  disposition will be treated
as  compensation  income (taxable at ordinary income rates) to the extent of the
excess,  if any, of the fair market  value of the Shares on the date of exercise
over the Exercise Price.

         (iv) Notice of Disqualifying  Disposition of ISO Shares.  If the Option
granted  to  Optionee  herein  is an ISO,  and if  Optionee  sells or  otherwise
disposes  of any of the  Shares  acquired  pursuant  to the ISO on or before the
later of (1) the date two years  after  the Date of  Grant,  or (2) the date one
year after transfer of such Shares to the Optionee upon exercise of the ISO, the
Optionee shall  immediately  notify the Company in writing of such  disposition.
Optionee  agrees that Optionee may be subject to income tax  withholding  by the
Company on the  compensation  income  recognized  by the Optionee from the early
disposition  by  payment  in cash  or out of the  current  earnings  paid to the
Optionee.

      OPTIONEE  ACKNOWLEDGES  AND AGREES THAT THE VESTING OF SHARES  PURSUANT TO
THE OPTION HEREOF IS EARNED ONLY BY CONTINUING  CONSULTANCY OR EMPLOYMENT AT THE
WILL OF THE COMPANY  (NOT  THROUGH THE ACT OF BEING  HIRED,  BEING  GRANTED THIS
OPTION OR ACQUIRING SHARES HEREUNDER).  OPTIONEE FURTHER ACKNOWLEDGES AND AGREES
THAT  NOTHING  IN THIS  OPTION,  NOR IN THE  COMPANY'S  1992 STOCK PLAN WHICH IS
INCORPORATED HEREIN BY REFERENCE, SHALL CONFER UPON OPTIONEE ANY


<PAGE>

RIGHT WITH RESPECT TO  CONTINUATION OF EMPLOYMENT OR CONSULTANCY BY THE COMPANY,
NOR  SHALL IT  INTERFERE  IN ANY WAY WITH HIS  RIGHT OR THE  COMPANY'S  RIGHT TO
TERMINATE HIS EMPLOYMENT OR CONSULTANCY AT ANY TIME, WITH OR WITHOUT CAUSE.

      Optionee   acknowledges  receipt  of  a  copy  of  the  Plan  and  certain
information,  related  thereto and represents that he is familiar with the terms
and  provisions  thereof,  and hereby  accepts this Option subject to all of the
terms and provisions of the Plan. Optionee has reviewed the Plan and this Option
in their entirety,  has had an opportunity to obtain the advice of counsel prior
to executing this Option and fully  understands all provisions  relating to this
Option.  Optionee  hereby agrees to accept as binding,  conclusive and final all
decisions or  interpretations  of the Board upon any questions arising under the
Plan or this Option.

                                                 /s/ Bruce Wright
Dated: March 24, 1997                            _______________________________
                                                 Optionee Signature


Dissolution, Merger or Assets Sale.

         Notwithstanding  the  foregoing  Vesting  Schedule,  in the  event of a
Change of Control of the Company,  the Optionee shall have the right to exercise
this Option as to all of the Shares,  including  Shares as to which it would not
otherwise be  exercisable.  "Change of Control" shall mean the occurrence of any
of the following events:

                   (i)  Any  "person"  or  "group"  (as  such  term  is  used in
Sections 13(d) and 14(d) of the Securities  Exchange Act of 1934, as amended) is
or becomes the  "beneficial  owner" (as defined in  Rule 13d-3  under said Act),
directly or indirectly, of securities of the Company representing 50% or more of
the total voting power  represented  by the Company's  then  outstanding  voting
securities; or

                   (ii) A change in the  composition of the Board of the Company
occurring within a two-year  period,  as a result of which fewer than a majority
of the directors  are  Incumbent  Directors.  "Incumbent  Directors"  shall mean
directors who either (A) are  directors of the Company as of the date hereof, or
(B) are elected, or nominated for election, to the Board of the Company with the
affirmative votes of at least a majority of the Incumbent  Directors at the time
of such  election  or  nomination  (but shall not  include an  individual  whose
election or  nomination  is in  connection  with an actual or  threatened  proxy
contest relating to the election of directors to the Company); or

                   (iii) The  shareholders  of the  Company  approve a merger or
consolidation of the Company with any other corporation,  other than a merger or
consolidation  which  would  result  in the  voting  securities  of the  Company
outstanding  immediately  prior  thereto  continuing  to  represent  (either  by
remaining  outstanding  or by being  converted  into  voting  securities  of the
surviving  entity)  more than  fifty  percent  (50%) of the total  voting  power
represented  by the voting  securities of the Company or such  surviving  entity
outstanding immediately after such merger or consolidation,  or the shareholders
of the  Company  approve a plan of  complete  liquidation  of the  Company or an
agreement for the sale or disposition by the Company of all or substantially all
the Company's assets (other than to a subsidiary or subsidiaries).


<TABLE>
<CAPTION>

                                             SEE REVERSE SIDE FOR STOCK OPTION AGREEMENT



MORRIONE, MICHAEL
3493 Varner Ct.
San Jose, CA 95132
                                                          [GRAPHIC OMITTED]

                                                        SPECTRIAN CORPORATION

                                                    NOTICE OF STOCK OPTION GRANT

You have been granted an option to purchase Common Stock of Spectrian  Corporation  (the "Company") under the terms of the Spectrian
Corporation 1992 Stock Plan as follows:

         <S>                                    <C>                        <C>                               <C>
         Grant Number                           003295                     Type of Option                    NQ
         Date of Grant                          1/15/97                    Plan                              96GG
         Option Price Per Share                 $9.5000                    Term/Expiration Date              1/15/2007
         Total Number of Shares Granted         40,000                     Vesting Commencement Date         2/3/97

Vesting Schedule: This Option shall be exercisable  cumulatively,  to the extent of 1/48th of the total Number of Shares Granted for
each full calendar month of your  Continuous  Status as an Employee or Consultant  since the Vesting  Commencement  Date;  provided,
however,  that this Option shall not be exercisable  prior to one year from the Vesting  Commencement  Date.  Termination  Period: 3
months after termination of employment or consulting relationship (but in no event later than the Expiration Date).

                                                                                             SPECTRIAN CORPORATION

                                                                                    By:      /s/ Garrett Garettson
                                                                                       -------------------------------
                                                                                    Title:            CEO
                                                                                          ----------------------------

This Notice of Grant does not  represent a stock  interest in the  Company,  which shall occur only upon the  exercise of this stock
option pursuant to its terms.

</TABLE>

<PAGE>


                              SPECTRIAN CORPORATION
                             STOCK OPTION AGREEMENT

      1. Grant of Option.  The Plan  Administrator of Spectrian  Corporation,  a
California  corporation (the "Company"),  hereby grants to the Optionee named in
the Notice of Grant (the  "Optionee"),  an option (the  "Option")  to purchase a
total number of shares of Common Stock (the "Shares") set forth in the Notice of
Grant,  at the  exercise  price per share set forth in the  Notice of Grant (the
"Exercise  Price")  subject  to the terms,  definitions  and  provisions  of the
Spectrian Corporation 1992 Stock Plan (the "Plan") adopted by the Company, which
is incorporated herein by reference.  Unless otherwise defined herein, the terms
defined in the Plan shall have the same defined meanings in this Option.

           If designated an Incentive  Stock Option,  this Option is intended to
qualify as an Incentive Option as defined in Section 422A of the Code.

      2. Exercise of Option. This Option shall be exercisable during its term in
accordance with the Vesting Schedule set out in the Notice of Grant and with the
provisions of Section 9 of the Plan as follows:

          (i)     Right to Exercise.

                  (a) This  Option  may not be  exercised  for a  fraction  of a
share.

                  (b) In the  event of  Optionee's  death,  disability  or other
termination  of  employment,  the  exercisability  of the Option is  governed by
Sections 7, 8 and 9 below,  subject to the  limitation  contained in  subsection
2(i)(c).
                  (c) In no event may this Option be exercised after the date of
expiration of the term of this Option as set forth in the Notice of Grant.

         (ii) Method of Exercise.  This Option shall be  exercisable  by written
notice (in the form  available  from the Company) which shall state the election
to exercise  the Option,  the number of Shares in respect of which the Option is
being  exercised,  and  such  other  representations  and  agreements  as to the
holder's investment intent with respect to such shares of Common Stock as may be
required by the Company  pursuant to the  provisions  of the Plan.  Such written
notice  shall be signed by the  Optionee  and shall be delivered in person or by
certified  mail to the  Secretary  of the Company.  The written  notice shall be
accompanied by payment of the exercise price.  This Option shall be deemed to be
exercised upon receipt by the Company of such written notice  accompanied by the
Exercise Price.

                  No Shares will be issued pursuant to the exercise of an Option
unless such issuance and such exercise shall comply with all relevant provisions
of law and the requirements of any stock exchange upon which the Shares may then
be listed. Assuming such compliance, for income tax purposes the Shares shall be
considered  transferred  to the  Optionee  on the date on which  the  Option  is
exercised with respect to such Shares.

      3.  Optionee's  Representations.  In  the  event  the  Shares  purchasable
pursuant  to the  exercise of this  Option  have not been  registered  under the
Securities  Act of 1933,  as  amended,  at the time this  Option  is  exercised,
Optionee  shall, if required by the Company,  concurrently  with the exercise of
all or any  portion  of this  Option,  deliver  to the  Company  his  Investment
Representation Statement in the form provided by the Company, and shall read the
applicable rules of the Commissioner of Corporations attached to such Investment
Representation Statement.


<PAGE>

      4. Method of Payment. Payment of the Exercise Price shall be by any of the
following, or a combination thereof, at the election of the Optionee:

          (i)     cash; or

         (ii)     check; or

        (iii) surrender of other shares of Common Stock of the Company which (A)
either have been owned by the  Optionee for more than six (6) months on the date
of surrender or were not acquired,  directly or indirectly, from the Company and
(B) have a fair  market  value on the date of  surrender  equal to the  Exercise
Price of the Shares as to which the Option is being exercised.

      5.  Restrictions on Exercise.  This Option may not be exercised until such
time as the Plan has been approved by the shareholders of the Company, or if the
issuance  of such  Shares  upon  such  exercise  or the  method  of  payment  of
consideration  for such shares would  constitute  a violation of any  applicable
federal or state securities or other law or regulation, including any rule under
Part  207 of Title 12 of the Code of  Federal  Regulations  ("Regulation  G") as
promulgated by the Federal Reserve Board. As a condition to the exercise of this
Option, the Company may require Optionee to make any representation and warranty
to the Company as may be required by any applicable law or regulation.

      6. Section 16 Restrictions.  Options granted to persons who are subject to
Section 16 of the Exchange Act ("Insiders") may not be exercised for a period of
at least  six  months  from the date of  grant,  except  in the case of death or
disability.

      7. Termination of Relationship.  In the event Optionee's Continuous Status
as an Employee or consultant  terminates,  Optionee may, to the extent otherwise
so entitled at the date of such termination (the "Termination  Date"),  exercise
this Option during the Termination Period set out in the Notice of Grant. To the
extent that  Optionee  was not  entitled to exercise  this Option at the date of
such  termination,  or if the Optionee  does not exercise this Option within the
time specified herein, the Option shall terminate.

      8.  Disability of Optionee.  Notwithstanding  the  provisions of Section 7
above, in the event  Optionee's  Continuous  Status as an Employee or Consultant
terminates as a result of total and permanent  disability (as defined in Section
22(e)(3) of the Code), Optionee may, but only within twelve (12) months from the
date of termination of employment or consultancy (but in no event later than the
date of expiration of the term of this Option as set forth in Section 11 below),
exercise  the Option to the extent  otherwise  so  entitled  at the date of such
termination. To the extent that Optionee was not entitled to exercise the Option
at the date of termination, or if Optionee does not exercise such Option (to the
extent otherwise so entitled) within the time specified herein, the Option shall
terminate.

      9.  Death of  Optionee.  The Option may be  exercised  at any time  within
twelve (12) months  after the  Optionee's  death (but in no event later than the
date of expiration of the term of this Option as set forth in Section 11 below),
by  Optionee's  estate or by a person who  acquired  the right to  exercise  the
Option by bequest or  inheritance,  but only to the  extent the  Optionee  could
exercise the Option at the date of death.

      10.  Non-Transferability  of Option. This Option may not be transferred or
assigned  in any  manner  otherwise  than by will or by the laws of  descent  or
distribution  and may be exercised  during the lifetime of Optionee only by him.
The terms of this Option  shall be binding upon the  executors,  administrators,
heirs, successors and assigns of the Optionee.


<PAGE>

      11. Term of Option.  This Option may be exercised only within the term set
out in the  Notice  of  Grant,  and may be  exercised  during  such term only in
accordance with the Plan and the terms of this Option.

      12. Tax Consequences. Set forth below is a brief summary as of the date of
this Option of some of the federal tax  consequences  of exercise of this Option
and disposition of the Shares. THIS SUMMARY IS NECESSARILY  INCOMPLETE,  AND THE
TAX LAWS AND  REGULATIONS  ARE SUBJECT TO CHANGE.  OPTIONEE SHOULD CONSULT A TAX
ADVISER BEFORE EXERCISING THIS OPTION OR DISPOSING OF THE SHARES.

          (i) Exercise of ISO. If this Option qualifies as an ISO, there will be
no regular  federal  income  tax  liability  upon the  exercise  of the  Option,
although the excess,  if any, of the fair market value of the Shares on the date
of exercise  over the  Exercise  Price will be treated as an  adjustment  to the
alternative minimum tax for federal tax purposes and may subject the Optionee to
the alternative minimum tax.

         (ii) Exercise of  Nonqualified  Stock  Option.  If this Option does not
qualify as an ISO, there may be a regular  federal income tax liability upon the
exercise  of the  Option.  The  Optionee  will be  treated  as  having  received
compensation  income (taxable at ordinary income tax rates) equal to the excess,
if any, of the fair market value of the Shares on the date of exercise  over the
Exercise  Price.  If Optionee is an  employee,  the Company  will be required to
withhold from  Optionee's  compensation  or collect from Optionee and pay to the
applicable  taxing   authorities  an  amount  equal  to  a  percentage  of  this
compensation income at the time of exercise.

        (iii)  Disposition of Shares.  In the case of an NSO, if Shares are held
for at least one year,  any gain realized on  disposition  of the Shares will be
treated as long-term  capital gain for federal income tax purposes.  In the case
of an ISO,  if Shares  transferred  pursuant to the Option are held for at least
one year after exercise and are disposed of at least two years after the Date of
Grant,  any gain realized on  disposition  of the Shares will also be treated as
long-term  capital gain for federal  income tax  purposes.  If Shares  purchased
under an ISO are  disposed  of within such  one-year  period or within two years
after the Date of Grant,  any gain realized on such  disposition will be treated
as  compensation  income (taxable at ordinary income rates) to the extent of the
excess,  if any, of the fair market  value of the Shares on the date of exercise
over the Exercise Price.

         (iv) Notice of Disqualifying  Disposition of ISO Shares.  If the Option
granted  to  Optionee  herein  is an ISO,  and if  Optionee  sells or  otherwise
disposes  of any of the  Shares  acquired  pursuant  to the ISO on or before the
later of (1) the date two years  after  the Date of  Grant,  or (2) the date one
year after transfer of such Shares to the Optionee upon exercise of the ISO, the
Optionee shall  immediately  notify the Company in writing of such  disposition.
Optionee  agrees that Optionee may be subject to income tax  withholding  by the
Company on the  compensation  income  recognized  by the Optionee from the early
disposition  by  payment  in cash  or out of the  current  earnings  paid to the
Optionee.

      OPTIONEE  ACKNOWLEDGES  AND AGREES THAT THE VESTING OF SHARES  PURSUANT TO
THE OPTION HEREOF IS EARNED ONLY BY CONTINUING  CONSULTANCY OR EMPLOYMENT AT THE
WILL OF THE COMPANY  (NOT  THROUGH THE ACT OF BEING  HIRED,  BEING  GRANTED THIS
OPTION OR ACQUIRING SHARES HEREUNDER).  OPTIONEE FURTHER ACKNOWLEDGES AND AGREES
THAT  NOTHING  IN THIS  OPTION,  NOR IN THE  COMPANY'S  1992 STOCK PLAN WHICH IS
INCORPORATED HEREIN BY REFERENCE, SHALL CONFER UPON OPTIONEE ANY


<PAGE>

RIGHT WITH RESPECT TO  CONTINUATION OF EMPLOYMENT OR CONSULTANCY BY THE COMPANY,
NOR  SHALL IT  INTERFERE  IN ANY WAY WITH HIS  RIGHT OR THE  COMPANY'S  RIGHT TO
TERMINATE HIS EMPLOYMENT OR CONSULTANCY AT ANY TIME, WITH OR WITHOUT CAUSE.

      Optionee   acknowledges  receipt  of  a  copy  of  the  Plan  and  certain
information,  related  thereto and represents that he is familiar with the terms
and  provisions  thereof,  and hereby  accepts this Option subject to all of the
terms and provisions of the Plan. Optionee has reviewed the Plan and this Option
in their entirety,  has had an opportunity to obtain the advice of counsel prior
to executing this Option and fully  understands all provisions  relating to this
Option.  Optionee  hereby agrees to accept as binding,  conclusive and final all
decisions or  interpretations  of the Board upon any questions arising under the
Plan or this Option.

                                                 /s/ Michael Morrione
Dated: March 20, 1997                            _______________________________
                                                 Optionee Signature


Dissolution, Merger or Assets Sale.

         Notwithstanding  the  foregoing  Vesting  Schedule,  in the  event of a
Change of Control of the Company,  the Optionee shall have the right to exercise
this Option as to all of the Shares,  including  Shares as to which it would not
otherwise be  exercisable.  "Change of Control" shall mean the occurrence of any
of the following events:

                   (i)  Any  "person"  or  "group"  (as  such  term  is  used in
Sections 13(d) and 14(d) of the Securities  Exchange Act of 1934, as amended) is
or becomes the  "beneficial  owner" (as defined in  Rule 13d-3  under said Act),
directly or indirectly, of securities of the Company representing 50% or more of
the total voting power  represented  by the Company's  then  outstanding  voting
securities; or

                   (ii) A change in the  composition of the Board of the Company
occurring within a two-year  period,  as a result of which fewer than a majority
of the directors  are  Incumbent  Directors.  "Incumbent  Directors"  shall mean
directors who either (A) are  directors of the Company as of the date hereof, or
(B) are elected, or nominated for election, to the Board of the Company with the
affirmative votes of at least a majority of the Incumbent  Directors at the time
of such  election  or  nomination  (but shall not  include an  individual  whose
election or  nomination  is in  connection  with an actual or  threatened  proxy
contest relating to the election of directors to the Company); or

                   (iii) The  shareholders  of the  Company  approve a merger or
consolidation of the Company with any other corporation,  other than a merger or
consolidation  which  would  result  in the  voting  securities  of the  Company
outstanding  immediately  prior  thereto  continuing  to  represent  (either  by
remaining  outstanding  or by being  converted  into  voting  securities  of the
surviving  entity)  more than  fifty  percent  (50%) of the total  voting  power
represented  by the voting  securities of the Company or such  surviving  entity
outstanding immediately after such merger or consolidation,  or the shareholders
of the  Company  approve a plan of  complete  liquidation  of the  Company or an
agreement for the sale or disposition by the Company of all or substantially all
the Company's assets (other than to a subsidiary or subsidiaries).


                                                                    Exhibit 23.1
 

                         Consent of Independent Auditors


The Board of Directors
Spectrian Corporation:


We consent to the  incorporation  herein by reference of our reports dated April
11, 1997 relating to the  consolidated  balance sheets of Spectrian  Corporation
and  subsidiary  as of March 31,  1997 and 1996,  and the  related  consolidated
statements of operations,  shareholders'  equity, and cash flows for each of the
years in the three-year  period ended March 31, 1997, and the related  schedule,
which  reports  appear or are  incorporated  by  reference in the March 31, 1997
annual report of Form 10-K of Spectrian Corporation.


/s/ KPMG Peat Marwick LLP
- -------------------------

KPMG Peat Marwick LLP
San Jose, California
October 17, 1997


                                      





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission